Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic Review
Open Access
- 23 September 2021
- journal article
- review article
- Published by Springer Nature in Neurotoxicity Research
- Vol. 39 (6) , 2120-2133
Abstract
Although MDMA (ecstasy) is a relatively safe recreational drug and is currently considered for therapeutic use for the treatment of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD), recreational MDMA use occasionally elicits hyperthermia and hyponatremia, sometimes with a fatal outcome. Specific risk factors for both adverse effects are profuse sweating while vigorously dancing under unfavorable conditions such as high ambient temperatures and insufficient fluid suppletion which result in dehydration. Concomitant use of MDMA and alcohol is highly prevalent, but adds to the existing risk, because alcohol facilitates the emergence of MDMA-induced adverse events, like hyperthermia, dehydration, and hyponatremia. Because of potential health-related consequences of concomitant use of MDMA and alcohol, it is important to identify the mechanisms of the interactions between alcohol and MDMA. This review summarizes the main drivers of MDMA-induced hyperthermia, dehydration, and hyponatremia and the role of concomitant alcohol use. It is shown that alcohol use has a profound negative impact by its interaction with most of these drivers, including poikilothermia, exposure to high ambient temperatures, heavy exercise (vigorous dancing), vasoconstriction, dehydration, and delayed initiation of sweating and diuresis. It is concluded that recreational and clinical MDMA-users should refrain from concomitant drinking of alcoholic beverages to reduce the risk for adverse health incidents when using MDMA.Keywords
This publication has 134 references indexed in Scilit:
- α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in HumansJournal of Clinical Psychopharmacology, 2013
- MDMA and temperature: A review of the thermal effects of ‘Ecstasy’ in humansDrug and Alcohol Dependence, 2012
- The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesBritish Journal of Pharmacology, 2010
- Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging studyBrain, 2010
- Role of α1‐ and β3‐adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouseBritish Journal of Pharmacology, 2009
- Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiologyJournal of Psychopharmacology, 2008
- When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: Effects of pretreatment with 5-HT1A and dopamine D2 antagonistsNeuroscience, 2008
- Patterns of Simultaneous Polysubstance Use in Canadian Rave AttendeesSubstance Use & Misuse, 2005
- Heat Illness in AthletesSports Medicine, 2004
- Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996–2002Human Psychopharmacology: Clinical and Experimental, 2003